Crowdstake

Odylia Therapeutics

EIN: 82-2120760 · Atlanta, GA

Gene Therapy Development

Our Story

Odylia Therapeutics is a pioneering nonprofit biotech organization dedicated to developing therapies for rare diseases that currently lack available treatments. By adopting a nonprofit drug development model, Odylia aims to overcome the economic barriers and misaligned incentives of traditional drug development, thereby accelerating the timeline and reducing costs associated with bringing new therapies to patients.

Impact

Committed to changing the lives of patients with rare diseases, Odylia Therapeutics utilizes a unique nonprofit business model to accelerate the development of gene therapies. The organization focuses on providing hope and improved health outcomes for individuals with genetic diseases, regardless of the prevalence of the condition.

Why Donate?

Your donation to Odylia Therapeutics supports the development of innovative treatments for rare diseases that lack commercial interest. Contributions help fund the organization's operational infrastructure, enabling it to identify and develop therapies, navigate clinical trials, and ensure safety and efficacy for patients in need.

Get Involved

Join the fight against rare diseases by donating today! Your support can make a significant difference in the lives of those affected by genetic conditions. Whether through cryptocurrency or cash, every contribution counts towards bringing life-changing treatments to patients in need.

Do you represent Odylia Therapeutics? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.